Science Explorer Back to mapMap
Institution · RxBio (United States)

Most cited papers from RxBio (United States)

What are the most cited papers from RxBio (United States)?

The most cited paper from RxBio (United States) is "The Lysophosphatidic Acid Type 2 Receptor Is Required for Protection Against Radiation-Induced Intestinal Injury" (Wenlin Deng, E Shuyu, Ryoko Tsukahara et al., 2007), with 122 citations. Next come "Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA2 Receptor-Specific Nonlipid Agonist" (44) and "Mitigation of the Hematopoietic and Gastrointestinal Acute Radiation Syndrome by Octadecenyl Thiophosphate, a Small Molecule Mimic of Lysophosphatidic Acid" (35).

Showing 10 of 10 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The Lysophosphatidic Acid Type 2 Receptor Is Required for Protection Against Radiation-Induced Intestinal Injury Wenlin Deng, E Shuyu, Ryoko Tsukahara et al. · Gastroenterology Open access 27 Mar 2007 122
2 Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA2 Receptor-Specific Nonlipid Agonist Renukadevi Patil, Erzsébet Szabó, James I. Fells et al. · Chemistry & Biology Open access 22 Jan 2015 44
3 Mitigation of the Hematopoietic and Gastrointestinal Acute Radiation Syndrome by Octadecenyl Thiophosphate, a Small Molecule Mimic of Lysophosphatidic Acid Wenlin Deng, Yasuhiro Kimura, Veeresh Gududuru et al. · Radiation Research Open access 25 Mar 2015 35
4 Structural Determinants of the Transient Receptor Potential 1 (TRPV1) Channel Activation by Phospholipid Analogs Sara L. Morales‐Lázaro, Bárbara Serrano‐Flores, Itzel Llorente et al. · Journal of Biological Chemistry Open access 18 Jul 2014 35
5 Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential Gábor Tigyi, Leonard R. Johnson, Sue Çhin Lee et al. · Journal of Lipid Research Open access 28 Jan 2019 27
6 Design and Synthesis of Sulfamoyl Benzoic Acid Analogues with Subnanomolar Agonist Activity Specific to the LPA2 Receptor Renukadevi Patil, James I. Fells, Erzsébet Szabó et al. · Journal of Medicinal Chemistry Open access 6 Aug 2014 15
7 Prevention and treatment of secretory diarrhea by the lysophosphatidic acid analog Rx100 Karin E. Thompson, Ramesh M. Ray, Shanta Alli et al. · Experimental Biology and Medicine Open access Sep 2018 11
8 Development of an LC–MS/MS assay to determine plasma pharmacokinetics of the radioprotectant octadecyl thiophosphate (OTP) in monkeys Hari Kosanam, Fei Ma, Hui He et al. · Journal of Chromatography B Open access 20 Jul 2010 9
9 Mechanisms of Radiomitigative Cell Signaling Via Lysophosphatidic Acid Receptors Gábor Tigyi, Gyongyi Nagyne‐Kiss, James I. Fells et al. · The FASEB Journal Apr 2012 0
10 Computational Design of a Non‐lipid LPA2 Receptor Agonist With Antiapoptotic and Radioprotective Action Gábor Tigyi, Gyongyi Nagyne‐Kiss, James I. Fells et al. · The FASEB Journal Apr 2011 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.